We here describe a leukemogenic role of the homeobox gene UNCX, activated by epigenetic modifications in acute myeloid leukemia (AML). We found the ectopic activation of UNCX in a leukemia patient harboring a t(7;10)(p22;p14) translocation, in 22 of 61 of additional cases [a total of 23 positive patients out of 62 (37.1%)], and in 6 of 75 (8%) of AML cell lines. UNCX is embedded within a lowmethylation region (canyon) and encodes for a transcription factor involved in somitogenesis and neurogenesis, with specific expression in the eye, brain, and kidney. UNCX expression turned out to be associated, and significantly correlated, with DNA methylation increase at its canyon borders based on data in our patients and in archived data of patients from The Cancer Genome Atlas. UNCX-positive and -negative patients displayed significant differences in their gene expression profiles. An enrichment of genes involved in cell proliferation and differentiation, such as MAP2K1 and CCNA1, was revealed. Similar results were obtained in UNCX-transduced CD34+ cells, associated with low proliferation and differentiation arrest. Accordingly, we showed that UNCX expression characterizes leukemia cells at their early stage of differentiation, mainly M2 and M3 subtypes carrying wild-type NPM1. We also observed that UNCX expression significantly associates with an increased frequency of acute promyelocytic leukemia with PML-RARA and AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 classes, according to the World Health Organization disease classification. In summary, our findings suggest a novel leukemogenic role of UNCX, associated with epigenetic modifications and with impaired cell proliferation and differentiation in AML.

Epigenetically induced ectopic expression of uncx impairs the proliferation and differentiation of myeloid cells / Daniele, G.; Simonetti, G.; Fusilli, C.; Iacobucci, I.; Lonoce, A.; Palazzo, A.; Lomiento, M.; Mammoli, F.; Marsano, R. M.; Marasco, E.; Mantovani, V.; Quentmeier, H.; Drexler, H. G.; Ding, J.; Palumbo, O.; Carella, M.; Nadarajah, N.; Perricone, M.; Ottaviani, E.; Baldazzi, C.; Testoni, N.; Papayannidis, C.; Ferrari, S.; Mazza, T.; Martinelli, G.; Storlazzi, C. T.. - In: HAEMATOLOGICA. - ISSN 0390-6078. - 102:7(2017), pp. 1204-1214. [10.3324/haematol.2016.163022]

Epigenetically induced ectopic expression of uncx impairs the proliferation and differentiation of myeloid cells

Lomiento M.;Mammoli F.;Marsano R. M.;Ferrari S.;
2017

Abstract

We here describe a leukemogenic role of the homeobox gene UNCX, activated by epigenetic modifications in acute myeloid leukemia (AML). We found the ectopic activation of UNCX in a leukemia patient harboring a t(7;10)(p22;p14) translocation, in 22 of 61 of additional cases [a total of 23 positive patients out of 62 (37.1%)], and in 6 of 75 (8%) of AML cell lines. UNCX is embedded within a lowmethylation region (canyon) and encodes for a transcription factor involved in somitogenesis and neurogenesis, with specific expression in the eye, brain, and kidney. UNCX expression turned out to be associated, and significantly correlated, with DNA methylation increase at its canyon borders based on data in our patients and in archived data of patients from The Cancer Genome Atlas. UNCX-positive and -negative patients displayed significant differences in their gene expression profiles. An enrichment of genes involved in cell proliferation and differentiation, such as MAP2K1 and CCNA1, was revealed. Similar results were obtained in UNCX-transduced CD34+ cells, associated with low proliferation and differentiation arrest. Accordingly, we showed that UNCX expression characterizes leukemia cells at their early stage of differentiation, mainly M2 and M3 subtypes carrying wild-type NPM1. We also observed that UNCX expression significantly associates with an increased frequency of acute promyelocytic leukemia with PML-RARA and AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 classes, according to the World Health Organization disease classification. In summary, our findings suggest a novel leukemogenic role of UNCX, associated with epigenetic modifications and with impaired cell proliferation and differentiation in AML.
2017
102
7
1204
1214
Epigenetically induced ectopic expression of uncx impairs the proliferation and differentiation of myeloid cells / Daniele, G.; Simonetti, G.; Fusilli, C.; Iacobucci, I.; Lonoce, A.; Palazzo, A.; Lomiento, M.; Mammoli, F.; Marsano, R. M.; Marasco, E.; Mantovani, V.; Quentmeier, H.; Drexler, H. G.; Ding, J.; Palumbo, O.; Carella, M.; Nadarajah, N.; Perricone, M.; Ottaviani, E.; Baldazzi, C.; Testoni, N.; Papayannidis, C.; Ferrari, S.; Mazza, T.; Martinelli, G.; Storlazzi, C. T.. - In: HAEMATOLOGICA. - ISSN 0390-6078. - 102:7(2017), pp. 1204-1214. [10.3324/haematol.2016.163022]
Daniele, G.; Simonetti, G.; Fusilli, C.; Iacobucci, I.; Lonoce, A.; Palazzo, A.; Lomiento, M.; Mammoli, F.; Marsano, R. M.; Marasco, E.; Mantovani, V.; Quentmeier, H.; Drexler, H. G.; Ding, J.; Palumbo, O.; Carella, M.; Nadarajah, N.; Perricone, M.; Ottaviani, E.; Baldazzi, C.; Testoni, N.; Papayannidis, C.; Ferrari, S.; Mazza, T.; Martinelli, G.; Storlazzi, C. T.
File in questo prodotto:
File Dimensione Formato  
8127-Article Text-55004-1-10-20200724.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 1.47 MB
Formato Adobe PDF
1.47 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1222868
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 6
social impact